Gilead Sciences reported $1.4B in Cost of Sales for its fourth fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Cost Of Sales Change
Abbvie ABBV:US USD 4.23B 86M
Acorda Therapeutics ACOR:US USD 11M 2.2M
Agios Pharmaceuticals AGIO:US USD 517K 82K
ALKERMES ALKS:US USD 50.62M 7.74M
Alnylam Pharmaceuticals ALNY:US USD 41.12M 308K
Amgen AMGN:US USD 1.75B 159M
Biogen BIIB:US USD 469.5M 14.5M
Biomarin Pharmaceutical BMRN:US USD 116.29M 6.84M
Bristol Myers Squibb BMY:US USD 2.52B 167M
Coherus Biosciences CHRS:US USD 35.23M 23.96M
Eli Lilly And LLY:US USD 1.55B 31M
Gilead Sciences GILD:US USD 1.4B 1000K
GlaxoSmithKline GSK:LN GBP 2.18B 209M
Glaxosmithkline GSK:US GBP 2.18B 209M
Intercept Pharmaceuticals ICPT:US USD 424K 115K
Johnson & Johnson JNJ:US USD 7.76B 29M
Merk MRK:US USD 3.36B 519M
Moderna Inc MRNA:US USD 1.1B 281M
Novartis NOVN:VX USD 3.84B 180M
Pfizer PFE:US USD 9.82B 3.73B
Ptc Therapeutics PTCT:US USD 14.01M 4.37M
Puma Biotechnology PBYI:US USD 12.5M 2.42M
Regeneron Pharmaceuticals REGN:US USD 540.6M 222.8M
Sarepta Therapeutics SRPT:US USD 39.95M 2.16M
Teva Pharmaceutical Industries TEVA:US USD 1.88B 73M
United Therapeutics UTHR:US USD 37.2M 7.5M